I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Prashant Pandey, Arghyadeep Marik, Aseem Tiwari, Sudipta Shekhar Das, Shamee Shastry, Vivek Kute, Mohit Chowdhry, Supriya Kumari, Divya Setya
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867001937191239680
author Prashant Pandey
Arghyadeep Marik
Aseem Tiwari
Sudipta Shekhar Das
Shamee Shastry
Vivek Kute
Mohit Chowdhry
Supriya Kumari
Divya Setya
author_facet Prashant Pandey
Arghyadeep Marik
Aseem Tiwari
Sudipta Shekhar Das
Shamee Shastry
Vivek Kute
Mohit Chowdhry
Supriya Kumari
Divya Setya
Prashant Pandey
Arghyadeep Marik
Aseem Tiwari
Sudipta Shekhar Das
Shamee Shastry
Vivek Kute
Mohit Chowdhry
Supriya Kumari
Divya Setya
collection Wiley Open Access
contents I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India Prashant Pandey Arghyadeep Marik Aseem Tiwari Sudipta Shekhar Das Shamee Shastry Vivek Kute Mohit Chowdhry Supriya Kumari Divya Setya Journal of Clinical Apheresis ABSTRACTABO‐incompatible transplantations are increasingly gaining relevance with advancements in therapeutic modalities, thus allowing patients to receive timely solid organ transplants. Therapeutic apheresis (TA) procedures remain instrumental as a preconditioning measure to enable such transplants. This survey was undertaken to find out current trends and practices of TA across major transplant centers in India. The survey was drafted by a working group of transfusion and transplant immunology specialists from six different centers in India. Data were obtained via the use of an online questionnaire. Results were categorized into eight categories: hospital information, range of titers for preconditioning, considerations prior to starting TA, TA procedure details, role of pharmacotherapy in TA, policy for reuse of columns, risk of rebound, and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of various TA procedures used across different major transplant centers in India. With the increase in ABO‐incompatible kidney and liver transplants across the country, the role of transfusion medicine and transplant immunology specialists have become vital in preconditioning regimes enabling the viability and success of such transplants. This was a unique survey that provided us a snapshot of current trends and practices of TA in preconditioning of patients for ABO‐incompatible transplants in India. 10.1002/jca.70003 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/jca.70003
format Artículo Open Access
id wiley_oa_10_1002_jca_70003
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India
Prashant Pandey
Arghyadeep Marik
Aseem Tiwari
Sudipta Shekhar Das
Shamee Shastry
Vivek Kute
Mohit Chowdhry
Supriya Kumari
Divya Setya
Journal of Clinical Apheresis
I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India Prashant Pandey Arghyadeep Marik Aseem Tiwari Sudipta Shekhar Das Shamee Shastry Vivek Kute Mohit Chowdhry Supriya Kumari Divya Setya Journal of Clinical Apheresis ABSTRACTABO‐incompatible transplantations are increasingly gaining relevance with advancements in therapeutic modalities, thus allowing patients to receive timely solid organ transplants. Therapeutic apheresis (TA) procedures remain instrumental as a preconditioning measure to enable such transplants. This survey was undertaken to find out current trends and practices of TA across major transplant centers in India. The survey was drafted by a working group of transfusion and transplant immunology specialists from six different centers in India. Data were obtained via the use of an online questionnaire. Results were categorized into eight categories: hospital information, range of titers for preconditioning, considerations prior to starting TA, TA procedure details, role of pharmacotherapy in TA, policy for reuse of columns, risk of rebound, and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of various TA procedures used across different major transplant centers in India. With the increase in ABO‐incompatible kidney and liver transplants across the country, the role of transfusion medicine and transplant immunology specialists have become vital in preconditioning regimes enabling the viability and success of such transplants. This was a unique survey that provided us a snapshot of current trends and practices of TA in preconditioning of patients for ABO‐incompatible transplants in India. 10.1002/jca.70003 http://onlinelibrary.wiley.com/termsAndConditions#vor
title I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India
topic Journal of Clinical Apheresis
url https://onlinelibrary.wiley.com/doi/10.1002/jca.70003